United Therapeutics Corporation (Nasdaq: UTHR) announced the completion of their two pivotal trials of OvaRex MAb for the treatment of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE